A mouse model of uropathogenic E. coli (UPEC) transurethral inoculation to establish latent intracellular bladder reservoirs and subsequent bladder exposure to G. vaginalis to induce recurrent UPEC UTI is demonstrated. Also demonstrated are the enumeration of bacteria, urine cytology, and in situ bladder fixation and processing for scanning electron microscopy.
Recurrent urinary tract infections (rUTI) caused by uropathogenic Escherichia coli (UPEC) are common and costly. Previous articles describing models of UTI in male and female mice have illustrated the procedures for bacterial inoculation and enumeration in urine and tissues. During an initial bladder infection in C57BL/6 mice, UPEC establish latent reservoirs inside bladder epithelial cells that persist following clearance of UPEC bacteriuria. This model builds on these studies to examine rUTI caused by the emergence of UPEC from within latent bladder reservoirs. The urogenital bacterium Gardnerella vaginalis is used as the trigger of rUTI in this model because it is frequently present in the urogenital tracts of women, especially in the context of vaginal dysbiosis that has been associated with UTI. In addition, a method for in situ bladder fixation followed by scanning electron microscopy (SEM) analysis of bladder tissue is also described, with potential application to other studies involving the bladder.
Urinary tract infections (UTI) impose a significant healthcare burden worldwide, impacting the quality of life of millions of people each year, especially women1. Uropathogenic Escherichia coli (UPEC) are the most frequent cause of UTI1. Many patients (approximately 20-30%) who develop UTI will experience a recurrent UTI (rUTI) within 6 months despite antibiotic-mediated clearance of the initial infection2. Unfortunately, as many as 5% of premenopausal women suffer from 3 or more rUTI each year3,4. Sequential episodes of rUTI can be caused by persistence of the same UPEC strain from the index case5,6,7,8. Data from human samples and mouse models suggest that same-strain rUTI could be caused by UPEC residing within quiescent reservoirs in the bladder. In humans, UPEC were detected in epithelial cells and bladder biopsies of patients with UTI9,10,11,12,13. Studies in C57BL/6 mice have demonstrated that some strains of UPEC can establish quiescent intracellular reservoirs in the bladder, as detected by fluorescence microscopy and by homogenization and culture of bladder tissue, that are maintained for months following resolution of bacteriuria14,15,16. Treatment of the bladder with agents that induce exfoliation of the bladder epithelium (urothelium), e.g. protamine sulfate17 or chitosan18, trigger emergence of UPEC from reservoirs to cause rUTI. These data suggest that in women harboring bladder UPEC reservoirs from a prior infection, bladder exposures that lead to urothelial exfoliation may trigger rUTI.
There is mounting evidence that the vaginal microbiota contributes to urinary tract infection19,20. Gardnerella vaginalis is a frequent member of both the vaginal and urinary microbiota21,22,23,24,25,26,27,28,29. In the vagina, the presence of high levels of G. vaginalis is associated with a microbial dysbiosis known as bacterial vaginosis (BV), which affects ~30% of women30,31,32. Women with BV are at a higher risk of experiencing UTI compared to women with a vaginal community dominated by Lactobacillus33,34,35,36,37. In mouse models, G. vaginalis causes epithelial exfoliation both in the vagina38 and in the bladder39. In C57BL/6 mice harboring UPEC bladder reservoirs, two sequential bladder exposures to G. vaginalis – but not to PBS – result in reemergence of UPEC from reservoirs to cause UPEC rUTI. The emergence is evidenced by the appearance of UPEC titers in urine from mice that had previously resolved UPEC bacteriuria and a subsequent decrease in UPEC bladder homogenate titers at sacrifice compared to PBS-exposed control animals39. Interestingly, there is not a lasting colonization by G. vaginalis in the bladder. In the vast majority of cases, two short exposures, each with less than 12 (h) of viable G. vaginalis in urine, are sufficient to elicit urothelial exfoliation and promote rUTI.
This protocol describes a mouse model of rUTI caused by UPEC residing in intracellular bladder reservoirs, using G. vaginalis bladder inoculation to trigger the recurrence. The advance achieved by this model is that G. vaginalis is a clinically relevant biological trigger of rUTI compared to previously used chemical agents. Further, the relatively short-lived survival of G. vaginalis in the mouse urinary tract allows examination of the impact of transient microbial exposures on the urothelium, as might occur after sexual activity. In addition to outlining the rUTI model, this protocol also describes methods for urine cytology and in situ bladder fixation and imaging of the urothelium by scanning electron microscopy (SEM).
This protocol of G. vaginalis-induced recurrent UPEC UTI uses UPEC strain UTI89 bearing a kanamycin resistance cassette (UTI89kanR)40. Not all strains of UPEC tested were able to form intracellular bacterial communities during the acute infection stage in mice41 and it is not yet known if all strains of UPEC have the ability to form latent intracellular reservoirs. Reservoir formation should be confirmed prior to use of other UPEC strains in the model. This protocol uses a spontaneous streptomycin-resistant G. vaginalis isolate, JCP8151BSmR38. Induction of rUTI by JCP8151BSmR requires two sequential G. vaginalis inoculations, given either 12 h or 7 days (d) apart39. Whether or not other G. vaginalis strains induce exfoliation and/or UPEC rUTI remains to be determined with this model. It is essential to use UPEC and G. vaginalis strains with known antibiotic resistance (such as kanamycin or spectinomycin for UPEC and streptomycin for G. vaginalis) because antibiotics can be added to agar plates to prevent growth of endogenous mouse microbiota that could otherwise interfere with enumerating colony-forming units (CFU) to monitor infection. This is especially important for culturing urine specimens, because mouse urine frequently contains other bacteria that can overgrow on culture plates without antibiotics. The origin of these endogenous bacteria in mouse urine is unknown but likely reflects periurethral and urogenital bacteria picked up during urine collection.
G. vaginalis is a facultative anaerobic bacterium and, therefore, this protocol describes growing G. vaginalis JCP8151BSmR in an anaerobic chamber. If an anaerobic chamber is not available, other methods for maintaining anaerobic growth conditions (such as a GasPak pouch in an airtight container) can be utilized. Alternatively, some strains of G. vaginalis (including JCP8151BSmR) will grow in a standard tissue-culture incubator (5% CO2). Just as using G. vaginalis strains other than JCP8151BSmR requires testing to ensure that the bacteria behave similarly in this model, changing growth conditions requires empirical determination of ideal durations for culture (on plates and in liquid) and optical density (OD)600 equivalents to achieve desired viable inoculum concentrations. Moreover, it is not known whether growth conditions influence the pathobiology of G. vaginalis.
Finally, when considering whether to utilize this model, researchers should be aware that it can require larger numbers of animals per group than do typical UTI mouse models. This is in part because induction of rUTI requires that the mice resolve the UPEC bacteriuria caused by the initial infection of the bladder. Thus, any mouse that fails to clear bacteriuria (a phenotype usually indicative of ongoing kidney infection) is not included in the rUTI phase of the protocol. The number of mice needed to power these studies is also influenced by the rate of "spontaneous" UPEC emergence into urine (12-14% on average). Finally, different mouse strains have different propensities for developing chronic bacteriuria versus intracellular reservoir formation42,43. If using mouse strains other than C57BL/6 in this model, it must be confirmed that the animals develop quiescent UPEC intracellular reservoirs.
The first critical step in this model to identify mice that have not cleared UPEC bacteriuria during the primary UTI phase. These mice must be removed from the experiment as they would otherwise confound the rates of UPEC bacteriuria after G. vaginalis exposure. After the initial UPEC inoculation, urine should be collected weekly to monitor bacterial clearance. Approximately 65-80% of C57BL/6 mice will clear a UTI89kanR infection within 4 weeks. Other inbred mouse strains have different propensities for UPEC clearance42,43 and reservoir formation and thus may not be suitable for this model. The second critical point is that empirical studies have determined that two sequential inoculations of G. vaginalis (either 12 h or 1 wk apart) are necessary to trigger significant reservoir emergence above the background spontaneous emergence that occurs in control mice exposed only to PBS. Other durations of time between the two sequential exposures have not been tested but could yield similar results. It is important to note that a reduction in UPEC bladder titers was only observed in the model in which G. vaginalis exposures were given 1 wk apart39. While more than two exposures can be administered, empirical evidence suggests that repeated catheterization alone increases emergence, which may confound the interpretation of the results or require larger numbers of animals to distinguish differences between exposure groups and controls. Finally, the in situ bladder fixation method has several critical steps. Some skill is required to ensure that the fixative remains inside the clamped bladders. Deflated bladders will be more difficult to image by SEM. It is also essential to be very gentle when inoculating the fixative into the bladder, as scraping the urothelium with the fixative-containing catheter can induce urothelial exfoliation independent of what is triggered by G. vaginalis. All concentrations mentioned in the fixative cocktail are final concentrations. Improper ratios of these can result in insufficient fixing and swelling or shrinkage of the cells. Fixatives should be warmed to physiological temperatures to avoid temperature shock in cells and tissues. Warming also provides a slight improvement to the diffusion rate of fixatives through plasma membranes. While osmium staining can often be omitted for samples prepared for SEM analysis, it is an essential step in this protocol to stabilize lipids and prevent cracking of cellular membranes during critical point drying.
This protocol can be modified to test other UPEC and/or G. vaginalis strains for their ability to form reservoirs and to trigger their emergence, respectively. Other experimental factors can also be added, such as exposure to other vaginal bacteria (e.g., Lactobacillus crispatus PVAS100) or heat-killed G. vaginalis, neither of which demonstrate pathology in this model39. When selecting other bacterial strains to test, it is important to demonstrate consistent growth such that a standard inoculum concentration can be used in all experiments. The growth of JCP8151BSmR has been optimized in an anaerobic chamber. This strain could likely be cultivated in an anaerobic GasPak system, but this would require optimization to ensure robust bacterial growth. Finally, it may be possible to modify the timing of certain steps in the model. For instance, urine can be collected at earlier timepoints during the UPEC reservoir formation phase to monitor CFU or host responses. An adverse effect of collecting urine samples at early timepoints (3, 6, 12 hpi) on the progression of infection or establishment of reservoirs has not been observed in this model. Emergence of UPEC reservoirs has been reported to occur after two JCP8151BSmR doses given 12 h or 1 wk, but other time intervals have not yet been tested. It also may be possible to reduce the overall length of time for the model by reducing the UPEC reservoir formation phase to 2 weeks (rather than 4 weeks), since many of the mice clear bacteriuria by this time. Previous studies examining UPEC emergence following bladder exposure to chemical exfoliants used a 1 or 2 wk UPEC reservoir formation phase17,18. However, decreasing the amount of time for UPEC bacteriuria clearance may come at the cost of requiring more animals to be culled from the experiment. Finally, SEM analysis of the bladder can be performed at additional time points to observe the duration of the effect of G. vaginalis on the urothelium.
Regarding troubleshooting, there are some important considerations specifically with respect to the bladder SEM analysis. Depending on the mouse background used and amount of inflammation present, some bladders will present with very thin walls. These bladders tend to curl more during critical point drying and can result in a cowrie shell-like shape. If this occurs, the best method is to cut the shell-shaped bladder in half along the curled interface and then a second time to remove the bulk of the overhanging tissue. Cutting works best with a PTFE-coated double-edged razor blade. Excess fat can sometimes solubilize during the osmium staining steps. This can result in unwanted insoluble fat droplets that may not wash off during the rinsing and dehydration steps and that can settle on the bladder surface during subsequent drying. These droplets can appear as either small spheres or disc-like structures scattered over the sample (Figure 4D). This can be mitigated by ensuring that as much adipose tissue is removed from around the bladder as possible. Platinum can be substituted for iridium coating, but thicknesses should be kept to a minimum to reduce the masking of fine structural details. The use of a rotating stage during coating is highly recommended.
One limitation of this model is that it requires a large number of mice. Only 65-80% of C57BL/6 mice will clear their UPEC bacteriuria and be suitable for subsequent G. vaginalis or PBS inoculation (see Figure 2C). To obtain 10-12 mice per group (G. vaginalis inoculation vs. PBS), ~30 mice should be initially infected with UPEC. Further, multiple experiments are likely required to achieve the biological replicates necessary to detect statistical significance. When exposures were given 1 wk apart, UPEC emergence occurred in 14% of mice exposed to PBS (Figure 3B). Thus, detecting a significant increase in UPEC rUTI in G. vaginalis exposed mice relative to PBS controls (powered at 0.8; alpha=0.05 [one sided]) requires testing a cumulative total of at least 40 mice for each exposure group. An additional consideration is that these experiments are expensive and labor-intensive. Mice must be monitored weekly for UPEC clearance and the experimental time course is 4-5 wk depending on whether G. vaginalis is given twice in a 12 h timeframe or twice 1 wk apart. SEM is labor-intensive and may be costly, depending on microscope availability and service charges. Preparing the entire bladder for SEM provides abundant material for analysis but the drawback is that analyzing each bladder can be time-consuming. Thus, it is likely that only a limited number of bladders can be analyzed by SEM compared to the higher animal numbers used for urine and tissue titers. In addition, obtaining high-quality images of the curved surfaces of the bladder "cups" requires skill due to shadows that can impede visibility. Although bladder SEM is a useful tool for visualizing urothelial exfoliation, this method is largely qualitative. Because the sample is fixed in a round shape, and due to the use of glutaraldehyde in the fixative, screening for fluorescently expressing bacteria via light microscopy is not possible. Immunostaining and chemical dyes are incompatible with this process due to the use of glutaraldehyde that will crosslink most antigens and osmium and that will mask antigen sites and darken the tissue. That said, the SEM technique is useful for parameters that can be evaluated quantitatively without the use of additional probes, such as cell size48,49.
This model offers several advantages beyond previously described methods. It allows the examination of mechanisms of UPEC rUTI caused by emergence from bladder reservoirs, as opposed to reintroduction into the bladder from an outside source. Other models of rUTI due to emergence from bladder reservoirs use chemical agents (protamine sulfate or chitosan) to cause urothelial exfoliation17,18, which would not be triggers of rUTI in women. G. vaginalis is a prevalent urogenital bacterium that has been detected in urine collected directly from the bladder via catheterization or suprapubic aspiration in some women23,26. This fact, coupled with the known association between BV (in which G. vaginalis overgrows in the vagina) and UTI, suggests that G. vaginalis is a clinically plausible trigger of rUTI. Finally, the in situ bladder fixation method preserves bladder ultrastructure and limits damage, ensuring that the bladder layers do not separate from one another. Previous methods for visualizing the urothelium traditionally have the user aseptically harvest, bisect, stretch, and pin the bladder onto a dissection tray before submerging the stretched bladder in fixative48. This method results in a very flat sample but does not ensure even or natural stretching of the tissue and can result in areas that are over and under stretched (resulting in highly wrinkled tissue) and can cause bladder layer separation. Additionally, these physical manipulations of the bladder to stretch and pin the tissue can cause damage, including urothelial exfoliation. Another method is to submerge intact bladders in fixative before embedding in paraffin and acquiring thin sections with a microtome. Thin sections are invaluable for immunohistochemistry experiments to examine bacteria and host protein localization but a thin section does not allow visualization of the urothelial surface. This SEM method allows the surface of the entire bladder to be examined at once.
As described, future applications of this model include testing other UPEC strains to determine whether they form intracellular reservoirs and testing other G. vaginalis strains to assess whether they elicit exfoliation and UPEC emergence to cause rUTI. Other mouse strains beyond C57BL/6 mice may also be tested, although mice with a high propensity for developing chronic cystitis (such as mice on the C3H background) are not recommended, since too many mice would need to be culled from the experiment. An additional advantage of C57BL/6 mice is that many genetic knockout strains are commercially available. Such strains provide an opportunity for interrogating the host factors involved in reservoir formation and/or emergence.
The authors have nothing to disclose.
The authors thank Lynne Foster for technical assistance in infection experiments, James Fitzpatrick at the Washington University Center for Celluar Imaging (WUCCI) for access to the SEM, Scott Hultgren for the UTI89kanR UPEC strain, and David Hunstad for critical reading of the manuscript.
This work was supported by the National Science Foundation (Graduate Research Fellowship to VPO#DGE – 1143954), by the Center for Women's Infectious Disease Research at Washington University School of Medicine (Pilot Research Award to NMG), by the American Heart Association: #12POST12050583 (NMG) and #14POST20020011 (NMG), and by the National Institutes of Health, NIAID: R01 AI114635 (ALL) and NIDDK: R21 DK092586 (ALL), P50 DK064540-11 (SJH, project II PI:ALL) and K01 DK110225-01A1 (NMG). Some of the animal studies were performed in a facility supported by NCRR grant C06 RR015502. The Washington University Center for Cellular Imaging (WUCCI; where SEM was performed) and MSJ were supported by the Washington University School of Medicine, the Children's Discovery Institute of Washington University and the St. Louis Children's Hospital (CDI-CORE-2015-505), the Foundation for Barnes-Jewish Hospital (3770), and the National Institute for Neurological Disorders and Stroke (NS086741). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
30G x 1/2 needles | BD | 305106 | for catheters |
5 1/2" straight forcep hemostat | McKesson | 487377 | in situ bladder fixation |
ACE 600 Sputter coater | Leica | SEM sample processing | |
aluminum SEM stub | Ted Pella | 16111 | SEM sample processing |
Calcium chloride | EMS | 12340 | in situ bladder fixation |
conductive carbon adhesive tab | Ted Pella | 16084-1 | SEM sample processing |
Conductive silver paint | Ted Pella | 16034 | SEM sample processing |
CPD 300 Critical Point Drier | Leica | SEM sample processing | |
Cytofunnel metal clip | Simport | M964B | cytospun urinalysis |
Ethanol | EMS | 15050 | SEM sample processing |
Glucose | Sigma | G7528 | for NYCIII G. vaginalis growth media |
glutaraldehyde | EMS | 16320 | in situ bladder fixation |
Hema 3 staining kit | Fisher | 23123869 | cytospun urinalysis |
HEPES | Cellgro | 25-060-Cl | for NYCIII G. vaginalis growth media |
iridium | Ted Pella | 91120 | SEM sample processing |
isofluorane | mouse anaesthesia | ||
kanamycin | Gibco | 11815024 | add to UPEC LB selective plates (50 ug/mL) |
Luria-Bertani agar | BD | DF0445174 | UPEC growth plates |
Luria-Bertani broth | BD | DF0446173 | UPEC growth media |
Merlin FE-SEM | Zeiss | scanning electron microscope | |
Milli-Q Water Purifier | Millipore | IQ-7000 | SEM sample processing |
NaCl | Sigma | S3014 | for NYCIII G. vaginalis growth media |
Olympus Vanox AHBT3 microscope | Olympus | cytospun urinalysis | |
osmium tetroxide | EMS | 19170 | SEM sample processing |
paraformaldehyde | EMS | 15710 | in situ bladder fixation |
polyethylene tubing | Intramedic | 427401 | for catheters |
Proteose Peptone #3 | Fisher | DF-122-17-4 | for NYCIII G. vaginalis growth media |
PTFE coated double edge razor blade | EMS | 72000 | cutting bladders for SEM |
Shandon Cytocentrifuge | Thermo Scientific | A78300002 | cytospun urinalysis |
Shandon cytofunnel filter | Simport | M965FWDV | cytospun urinalysis |
Shandon Double cytofunnel | Simport | M964-1D | cytospun urinalysis |
Shandon double cytoslides (coated) | Thermo Scientific | 5991055 | cytospun urinalysis |
sodium cacodylate trihydrate | EMS | 12310 | in situ bladder fixation |
spectrophotometer | BioChrom | 80-3000-45 | measuring bacterial OD600 |
streptomycin | Gibco | 11860038 | add to G. vaginalis NYCIII selective plates (1 mg/mL) |
tuberculin slip tip syringe | BD | 309659 | for catheters |
Yeast Extract | Fisher | DF0127-17-9 | for NYCIII G. vaginalis growth media |